dosis dan respon obat

of 21/21
HUBUNGAN DOSIS, KONSENTRASI DENGAN RESPON OBAT Oleh : Neni Anggraeni 0120150011 Mata Kuliah : Farmakodinamik Dosen Pengampu : Kuswinarti, Dra., MS, Apt

Post on 13-Jul-2016




33 download

Embed Size (px)


hubungan dosis, konsentrasi terhadap respon obat


  • HUBUNGAN DOSIS, KONSENTRASI DENGAN RESPON OBATOleh : Neni Anggraeni (130120150011Mata Kuliah : FarmakodinamikDosen Pengampu : Kuswinarti, Dra., MS, Apt

  • Obat dapat memberikan respon ketika berikatan dengan suatu reseptor

    Dosis Manfaat maksimum & Toksisitas minimum

    Dosis & Respon pada PasienVariasi dalam respon obatSelektivitas klinik

  • Dosis & Respon pada PasienGraded Dose-Respon RelationUntuk Menentukan dosis obat yang tepat, harus diketahui mengenai The relative pharmacologic potency and maximal efficacy

  • PotencyDrugs A and B more potent than drugs C and D

    Potensi bergantung pada :Kemampuan obat tersebut mencapai reseptor yang sesuaiCara pemberianAbsorbsi DistribusiKlirens dari darah atau tempat kerjanya Potensi suatu obat harus dinyatakan dalam unit dosis. 50 mg untk sedasi ringan, 1g/kg/men untuk peningkatan denyut jantung

  • 2. Maximal EfficayThis parameter reflects the limit of the dose-response relation on the response axis.Drugs A, C, and D have equal maximal efficacy, and all have greater maximal efficacy than drug B. Efekasi ditentukan oleh interaksi obat dengan reseptor atau oleh reseptor-efektor yang terlibat

  • Dosis & Respon pada PasienShape of Dose-Response Curves Respon yang terlihat dalam kurva A,B,C mendekati hubungan Michaelis-Menten Kurva yang curam (D) mempunyai konsekuensi klinik yang penting. (koma hipnotik-sedativ)Kurva yang curam diakibatkan interaksi kooperatif dari beberapa kerja suatu obat yang berbeda.Sifat Farmakokinetik suatu obat

  • Dosis & Respon pada PasienQuantal Dose-Effect Curves Graded dose-response curves of the sort described above have certain limitations in their application to clinical decision making if the pharmacologic response is an either-or (quantal) event, such as prevention of convulsions, arrhythmia, or death

  • Dosis & Respon pada PasienDetermining the dose of drug required to produce a specified magnitude of effect in a large number of individual patients or experimental animals and plotting the cumulative frequency distribution of responders versus the log dose. Quantal Dose-Effect Curves

  • Dosis & Respon pada PasienQuantal Dose-Effect CurvesMedian effective dose (ED50) = is the dose at which 50% of individuals exhibit the specified quantal effect. Median toxic dose (TD50) = the dose required to produce a particular toxic effect in 50% of animals If the toxic effect is death of the animal = median lethal dose (LD50)

  • Dosis & Respon pada PasienQuantal Dose-Effect CurvesJika ada dua obat A dan B menghasilkan ED50, A = 5mg dan B = 500 mg. Maka obat A 100 kali lebih kuat untuk menghasilkan efek kuantal tertentu

  • Dosis & Respon pada PasienQuantal Dose-Effect CurvesDapat memberikan informasi mengenai batas keamanan suatu obat.

    Indeks terapi = ukuran yang menghubunkan dosis obat untuk menghasilkan efek yang diingingkan terhadap efek yang tidak diinginkan

    Indeks terapi = rasio TD50 terhadap ED50.

  • Dosis & Respon pada PasienQuantal Dose-Effect CurvesVs Shape of Dose-Response Curves Both curves provide information regarding the potency and selectivity of drugs; the graded dose-response curve indicates the maximal efficacy of a drug, and the quantal doseeffect curve indicates the potential variability of responsiveness among individuals.

  • Variasi dalam Respon ObatIndividuals may vary considerably in their response to a drug Idiosyncratic drug response. Genetik atau mekanisme imunologi (alergi) hyporeactive hyperreactive 4 general mechanisms may contribute to variation in drug responsiveness :

    Alteration in Concentration of Drug That Reaches the ReceptorVariation in Concentration of an Endogenous Receptor LigandAlterations in Number or Function of ReceptorsChanges in Components of Response Distal to the Receptor

  • Alteration in Concentration of Drug That Reaches the ReceptorVariasi dalam Respon Obatpatients may differ in :the rate of absorption of a drug distributing it through body compartmentsclearing the drug from the blood Some differences can be predicted on :AgeWeightSexDisease stateLiver and kidney Genetic differences

  • Variation in Concentration of an Endogenous Receptor Ligand Variasi dalam Respon ObatThis mechanism contributes greatly to variability in responses to pharmacologic antagonists propranolol, a -adrenoceptor antagonist, markedly slows the heart rate of a patient whose endogenous catecholamines are elevated (as in pheochromocytoma) but does not affect the resting heart rate of a well-trained marathon runner.

  • Alterations in Number or Function of ReceptorsVariasi dalam Respon ObatIn some cases, the change in receptor number is caused by other hormones; for example, thyroid hormones increase both the number of -andrenoreceptors in rat heart muscle and cardiac sensitivity to catecholamines. In other cases, the agonist ligand itself induces a decrease in the number (eg, down-regulation) or coupling efficiency (eg,desensitization) of its receptors.

    Genetic factors also can play an important role in altering the number or function of specific receptors. For example, a specific genetic variant of the 2C adrenoceptor when inherited together with a specific variant of the 1 adrenoceptorconfers increased risk for developing heart failure, which may be reduced by early intervention using antagonist drugs.

  • Changes in Components of Response Distal to the ReceptorVariasi dalam Respon ObatAlthough a drug initiates its actions by binding to receptors, the response observed in a patient depends on the functional integrity of biochemical processes in the responding cell and physiologic regulation by interacting organ system

  • Selektivitas Klinikno drug causes only a single, specific effect. In drug development and in clinical medicine, selectivity is usually considered by separating effects into two categories: beneficial or therapeutic effects versus toxic or adverse effects

  • Selektivitas KlinikBeneficial and Toxic Effects Mediated by the Same Receptor-Effector MechanismMuch of the serious drug toxicity in clinical practice represents a direct pharmacologic extension of the therapeutic actions of the drug a drug is clearly necessary and beneficial but produces unacceptable toxicity when given in doses that produce optimal benefit.

    Contoh : Guenetidin. Menurunkan tekanan darah pada hipertensi esensial dgn menghambat stimulasi kardiovaskuler oleh safa simpatis. Jika dosis cukup besar pasien akan mengalamai hipotensi postural.

  • Selektivitas KlinikBeneficial and Toxic Effects Mediated by Identical Receptors but in Different Tissues or by Different Effector PathwayMany drugs produce both their desired effects and adverse effects by acting on single receptor type in different tissues. Ex. Digitalis glycosides, which act by inhibiting Na+/K+-ATPase in cell membranes; methotrexate, which inhibits the enzyme dihydrofolate reductase; and glucocorticoid hormones. Three therapeutic strategies are used to avoid or mitigate this sort of toxicity. the drug should always be administered at the lowest dose that produces acceptable benefit.Adjunctive drugs that act through different receptor mechanisms and produce different toxicities may allow lowering the dose of the first drug, thus limiting its toxicity.Selectivity of the drugs actions may be increased by manipulating the concentrations of drug available to receptors in different parts of the body

  • Selektivitas KlinikBeneficial and Toxic Effects Mediated by Different Types of ReceptorsTherapeutic advantages resulting from new chemical entities with improved receptor selectivity were mentioned earlier in this chapter and are described in detail in later chapters. Such drugs include - and -selective adrenoceptor agonists and antagonists, H1 and H2 antihistamines, nicotinic and muscarinic blocking agents, and receptor-selective steroid hormones